Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax vaccine: a review.

John D Grabenstein1

  • 1US Army Medical Command, 5111 Leesburg Pike, Falls Church, VA 22041, USA. john.Grabenstein@amedd.army.mil

Immunology and Allergy Clinics of North America
|February 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacy-Based Immunization Delivery: A Comprehensive History and Current Challenges.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Pharmacists' answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics-United States.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

Vaccines against mpox: MVA-BN and LC16m8.

Expert review of vaccines·2024
Same author

Pharmacist assessments and care to improve adult vaccination rates: A report from project IMPACT vaccine confidence.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

Effect of an Innovative Immunization Practice Model to Improve Population Health: Results of the Project IMPACT Immunizations Scaled Demonstration.

Innovations in pharmacy·2023
Same author

Evaluating risk of bias using ROBINS-I tool in nonrandomized studies of adjuvanted influenza vaccine.

Vaccine·2023

Early anthrax treatment is critical. A US vaccine, available since 1970 and widely used since 1998, is confirmed safe and effective by the National Academy of Sciences.

Area of Science:

  • Medical Microbiology
  • Vaccinology
  • Public Health

Background:

  • Anthrax is a severe infectious disease requiring prompt medical intervention.
  • An anthrax vaccine has been available in the United States since 1970.
  • Widespread vaccine use commenced in 1998.

Purpose of the Study:

  • To evaluate the safety and efficacy of the US-licensed anthrax vaccine.
  • To review existing scientific evidence on anthrax vaccination.
  • To provide a comprehensive assessment of the vaccine's performance.

Main Methods:

  • Review of peer-reviewed scientific literature.
  • Analysis of data from independent expert panels.
  • Evaluation by the National Academy of Sciences.

Related Experiment Videos

Main Results:

  • The US-licensed anthrax vaccine is safe.
  • The US-licensed anthrax vaccine is effective.
  • Multiple independent reviews corroborate safety and efficacy findings.

Conclusions:

  • The anthrax vaccine is a reliable tool for preventing anthrax.
  • Continued confidence in the US anthrax vaccine is warranted.
  • Early diagnosis and treatment remain crucial for managing anthrax infections.